andrewdudum
@AndrewDudum • 57,263 subscribers
Founder & CEO $HIMS.
Shorts
Videos
Customer access should move at the same speed as innovation. When the healthcare industry works together to reach individuals, it does. Since last week, thousands of people have signed up for our Wegovy® waitlist. Starting today, eligible Hims & Hers customers can start their journeys with Novo Nordisk’s FDA-approved Wegovy® Pill & Wegovy® Pen and partner with their provider on a comprehensive weight loss program designed to help them achieve their goals. We take our role as the largest global consumer health platform seriously, and I can’t wait to keep finding ways to make sure everyone can access the tools they need to feel great. Read more below from Dr. Craig, our Head of Weight Loss, on what’s available today. (And if you’re starting your Wegovy journey with us today, tag me and tell me how it’s going!) More details, including important info, here:
andrewdudum93,264 görüntüleme • 3 ay önce
This morning we launched Labs, the easiest and most comprehensive way to get a real understanding of your health. Labs offers an annual subscription that tests up to 120 of the most critical biomarkers in your body, for just a few hundred dollars. From genetic cardiovascular numbers to metabolic syndrome, these are the biomarkers at the cutting edge of innovation. Data is helpful, but what comes next is what matters. Immediately when your results are in, our platform in partnership with thousands of doctors, nurses and providers will provide you with a specific analysis and action plan. Nutrition, movement, supplements, and personalized medication options. With over 1M square feet of pharmacy infrastructure, Hims & Hers doesn’t just test your health metrics, but unlocks your ability to actually improve them with access to precision treatments and care. This is the first offering with Hims & Hers I’m encouraging all of my family and friends to sign up for. The power of knowledge and early action is unmatched, and for the people we love there is no greater gift.
andrewdudum136,578 görüntüleme • 8 ay önce
For years, there has been a huge opportunity to transform the healthcare experience for women. We built hers in 2018 to lead that transformation. And it’s working, the Hers business is scaling fast, on track to hit $1B in 2026. Today, we’re launching Menopause and Perimenopause by Hers, powered by Jessica Shepherd, MD, MBA, FACOG’s expertise and passion, supporting more women ready for care on their own terms. Listen to what she has to say.
andrewdudum117,907 görüntüleme • 9 ay önce
We just shared our Q1 results. And our 2030 target: $6.5B in revenue, $1.3B in adjusted EBITDA. We're entering a new era of growth: deeper personalization, broader impact, and faster execution. The foundation is set. The roadmap is clear. We're just getting started.
andrewdudum73,400 görüntüleme • 1 yıl önce
Latest $hims TV spot debut! Excited for this to start airing. Our creative team continuing to deliver 🔥
andrewdudum43,279 görüntüleme • 2 yıl önce
Daha fazla içerik yok.